EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

PD-L1 Expression in NSCLC: Clouds in a Bright Sky

Victoria Ferrari iD, Jocelyn Gal iD, Baharia Mograbi iD, Gerard Milano

International Journal of Molecular Sciences · 24.06.2025 · 26 (13) · 6066

DOI: 10.3390/ijms26136066 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 24.06.2025. Verfasst von Victoria Ferrari und 3 weiteren Autor:innen. Beteiligte Einrichtung: Antoine Lacassagne Center, Department of Medical Oncology, University Côte d'Azur, 33 Avenue de Valombrose, 06189 Nice, France. Hauptthemen laut MEDLINE: B7-H1 Antigen, Lung Neoplasms, Carcinoma, Non-Small-Cell Lung. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: French national research agency, IDEX reference, “Investments for the Future” LABEX SIGNALIFE.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Programmed Death-Ligand 1 (PD-L1) is a major target for immunotherapy using checkpoint inhibitors (CPIs), particularly in lung cancer treatment. Tumoral PD-L1 expression has been recognized as a natural predictor of CPI response. This predictive relationship is primarily due to its upregulation by interferon-gamma, which is released by immune cells (mainly T lymphocytes and natural killer cells) in proximity to tumor cells, driving an immune resistance mechanism. However, PD-L1 expression is modulated at multiple levels, including oncogenic signaling pathways, and transcriptional and post-transcriptional regulations, potentially leading to false positive predictions. Conversely, variable glycosylation of PD-L1 may compromise the accuracy of immunohistochemical measurements, resulting in false negative predictive data. In addition, PD-L1 expression demonstrates relative instability throughout treatment courses (e.g., chemotherapy and tyrosine kinase inhibitors), further limiting its clinical utility. In this review, we focused on the molecular mechanisms governing PD-L1 expression with a special emphasis on lung cancer. We also discussed biomarker strategies for optimizing patient selection for checkpoint inhibitor therapy where multimodal/multi-omics meta-biomarker approaches are emerging. Such comprehensive PD-L1-enriched biomarker strategies require evaluation through large-scale prospective studies, particularly in lung cancer, where numerous competing predictive candidates exist for CPI response.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

B7-H1 AntigenLung NeoplasmsCarcinoma, Non-Small-Cell LungHumansBiomarkers, TumorImmune Checkpoint InhibitorsGene Expression Regulation, NeoplasticImmunotherapy

Stichwörter der Autor:innen

PD-L1gene expressionimmunotherapynon-small cell lung cancer

Substanzen

B7-H1 AntigenCD274 protein, humanBiomarkers, TumorImmune Checkpoint Inhibitors

Autor:innen und Institutionen

  • Antoine Lacassagne Center, Department of Medical Oncology, University Côte d'Azur, 33 Avenue de Valombrose, 06189 Nice, France.
  • Antoine Lacassagne Center, Department of Epidemiology and Biostatistics, University Côte d'Azur, 33 Avenue de Valombrose, 06189 Nice, France.
  • FHU OncoAge, IHU RespirERA, IRCAN, Inserm, CNRS 7284, U1081, University Côte d'Azur, 06189 Nice, France.
  • Antoine Lacassagne Center, University Côte d'Azur, 33 Avenue de Valombrose, 06189 Nice, France.

ORCID-Profile: Victoria Ferrari, Jocelyn Gal, Baharia Mograbi

Förderung

  • French national research agency
  • IDEX reference
  • “Investments for the Future” LABEX SIGNALIFE

Zitieren

APA

Ferrari, V., Gal, J., Mograbi, B., & Milano, G. (2025). PD-L1 Expression in NSCLC: Clouds in a Bright Sky. International Journal of Molecular Sciences, 26(13), 6066. https://doi.org/10.3390/ijms26136066

Vancouver

Ferrari V, Gal J, Mograbi B, Milano G. PD-L1 Expression in NSCLC: Clouds in a Bright Sky. International Journal of Molecular Sciences. 2025;26(13):6066. doi:10.3390/ijms26136066

BibTeX
@article{Ferrari2025,
  author = {Ferrari, Victoria and Gal, Jocelyn and Mograbi, Baharia and Milano, Gerard},
  title = {PD-L1 Expression in NSCLC: Clouds in a Bright Sky},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  volume = {26},
  number = {13},
  pages = {6066},
  doi = {10.3390/ijms26136066}
}
Kostenlos starten →